A novel fifteen minute test for assessment of individual time-dependent clotting responses to aspirin and clopidogrel using modified thrombelastography

Platelets

Volumn 18, Issue 7, 2007, Pages 497-505

  Hobson, Alex R ^a   Petley, Graham W ^a   Dawkins, Keith D ^a   Curzen, Nick ^a,b,c  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Aspirin; Clopidogrel; Platelet; Thrombelastography

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD CLOTTING TIME; CONTROLLED STUDY; FEMALE; GENETIC HETEROGENEITY; HUMAN; HUMAN EXPERIMENT; LOADING DRUG DOSE; MALE; NORMAL HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SINGLE DRUG DOSE; THROMBOELASTOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; ASPIRIN; BLOOD COAGULATION; FEMALE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; REPRODUCIBILITY OF RESULTS; THROMBELASTOGRAPHY; TICLOPIDINE;

EID: 35649021844     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100701329162     Document Type: Article

References (24)

1. Morton G, Hobson A, Dawkins KD, Curzen N. Stent thrombosis in 3004 consecutive patients in a single UK centre. Am J Cardiol 2006;98(Suppl 8A):180M-181M.
2. Drug-eluting stent late thrombosis meta-analysis. Presented by E. Camezind. WCC Scientific Congress, Barcelona, Spain. September 2006.
3. Cheneau E, Leborgne L, Mintz GS, Kotani J, Pichard AD, Satler LF, Canos D, Castagna M, Weissman NJ, Waksman R. Predictors of subacute stent thrombosis: Results of a systematic intravascular ultrasound study. Circulation 2003;108:43-47.
4. Wenaweser P, Dorffler MJ, Imboden K, Windecker S, Togni M, Meier B, Haeberli A, Hess OM. Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol 2005;45:1748-1752.
5. Gurbel PA, Bliden KP, Samara W, Yoho JA, Hayes K, Fissha MZ, Tantry US. Clopidogrel effect on platelet reactivity in patients with stent thrombosis: Results of the CREST Study. J Am Coll Cardiol 2005;46:1827-1832.
6. Jaremo P, Lindahl TL, Fransson SG, Richter A. Individual variations of platelet inhibition after loading doses of clopidogrel. J Intern Med 2002;252:233-238.
7. Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006;367:606-617.
8. Swallow RA, Agarwala RA, Dawkins KD, Curzen NP. Thrombelastography: A novel bedside tool to assess the effects of antiplatelet therapy? Platelets 2006;17:385-392.
9. Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: Response variability, drug resistance and the effect of pre-treatment platelet reactivity. Circulation 2003;107:2908-2913.
10. Lev EI, Patel RT, Maresh KJ, Guthikonda S, Granada J, Delao T, Bray PF, Kleiman NS. Aspirin and clopidogrel drug response in patients undergoing percutaneous intervention: The role of dual drug resistance. J Am Coll Cardiol 2006;47:27-33.
11. Chen WH, Lee PY, Ng W, Tse HF, Lau CP. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous intervention despite clopidogrel pre-treatment. J Am Coll Cardiol 2004;43:1122-1126.
12. Steinhubl SR, Talley JD, Braden GA, Tcheng JE, Casterella PJ, Moliterno DJ, et al. Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous intervention: Results of the GOLD (AU-Assessing Ultegra) multicentre study. Circulation 2001;103:2572-2578.
13. Bowbrick VA, Mikhailidis DP, Stansby G. Value of thrombelastography in the assessment of platelet function. Clin Appl Thromb Hemost 2003;9:137-142.
14. Hobson AR, Agarwala RA, Swallow RA, Dawkins KD, Curzen NP. Thrombelastography: Current clinical applications and its potential role in interventional cardiology. Platelets 2006;17:509-18.
15. Tantry US, Bliden KP, Gurbel PA. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachadonic acid stimulation. J Am Coll Cardiol 2005;46:1705-1709.
16. Craft RM, Chavez JJ, Bresee SJ, Wortham DC, Cohen E, Carroll RC. A novel modification of the thrombelastograph assay, isolating platelet function, correlates with optical aggregation. J Lab Clin Med 2004;143:301-309.
17. Mobley JE, Bresee SJ, Wortham DC, Craft RM, Snider CC, Carroll RC. Frequency of nonresponse antiplatelet activity of clopidogrel during pre-treatment for cardiac catheterisation. Am J Cardiol 2004;93:456-458.
18. Lisman T, Weeterings C, de Groot PG. Platelet aggregation: Involvement of thrombin and fibrin(ogen). Front-Biosci 2005;10:2504-2517.
19. Schwartz KA, Schwartz DE, Ghosheh K, Reeves MJ, Barber K, DeFranco EA. Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction. Am J Cardiol 2005;95:973-975.
20. Carroll RC, Craft RM, Chavez JJ, Snider CC, Bresee SJ, Cohen E. A Thromboelastogram whole blood assay for clinical monitoring of NSAID-insensitive transcellular platelet activation by arachidonic acid. J Lab Clin Med 2005;146:30-35.
21. Bhattacharyya S, Riddell A, Rakhit R. The synergistic effect of the addition of clopidogrel to aspirin in reducing functional aspirin resistance in patients undergoing elective percutaneous intervention. Heart 2006;92(Suppl 11):A6.
22. Mirkel A, Peyster E, Sundeen J, Greene L, Michelson A, Hasan A, Domanski M. Frequency of aspirin resistance in a community hospital. Am J Cardiol 2006;98:577-579.
23. Hochholzer W, Trenk D, Frundi D, Blanke P, Fischer B, Andris K, Besterhorn H-P, Buttner H, Neumann F-J. Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous intervention. Circulation 2005;111:2560-2564.
24. Gurbel PA, Bliden KP, Zaman KA, Yoho JA, Hayes KM, Tantry US. Clopidogrel loading with eptifibatide to arrest the reactivity of platelets. Results of the clopdiogrel loading with eptifibatide to arrest the reactivity of platelets (CLEAR PLATELETS) study. Circulation 2005;111:1153-1159.